LMSSitesePortfolio註冊登入
位置 : 首頁 > 最新文章
編號 標題 社群 人氣 建立時間
4307 P-07 Expression of MYCN mRNA in early neuroblastoma development of MYCN-transgenic mice 467 10-10 23:43
4306 P-06 H1FX is a potent downstream factor of midkine in neuroblastoma 572 10-10 23:39
4305 P-05 Neuroblastoma sphere specific gene regulates stemness pathway for cancer stem cells 539 10-10 23:37
4304 P-04 Feasibility of delayed local control treatment in patient with high risk Neuroblastoma: Report of a pilot study from the Japan Neuroblastoma study group(JN-H-05) 511 10-10 23:34
4303 P-03 KIR-ligand incompatibility in the graft-versus-host direction improves progression-free survival in patients with primary high risk neuroblastoma after umbilical cord blood transplantation 541 10-10 23:25
4302 P-02 Determination of timing of surgery based on IDRF: an observation study for low risk neuroblastomas (JN-L-10) 491 11-10 23:23
4301 P-01 Effects of MAPK inhibitors on neuroblastoma 585 10-10 23:18
4300 O-12 Identification of ALK-binding phosphotyrosine-containing proteins as the critical regulators of oncgenic properties of Neuroblastoma cells 459 10-10 23:15
4299 O-11 The Roles of Innate Immunity in the Treatment of Neuroblastoma 500 10-10 23:13
4298 O-10 Epigenetic and gene expression analysis of the crucial early events for neuroblastoma tumorigenesis in MYCN-Tg mice 736 10-10 23:11
4297 O-09 Genomic characterization of aggressive subtypes of neuroblastoma with 11q partial loss 414 10-10 23:08
4296 O-08 Update the roles of glycolytic inhibitors in the treatment of neuroblastoma 354 10-10 23:05
4295 O-07 ALK inhibition enhances NLRR1/EGFR pathway dependency with nucleolus alteration in neuroblastoma 446 10-10 23:02
4294 O-06 Unusual Suspects Identified in Neuroblastoma – An Unexpected Cell Death Pathway 382 10-10 22:58
4293 O-05 A new therapeutic strategy of neuroblastoma by Liquid biopsy 478 10-10 22:54
4292 O-04 MR-PET in Children with neuroblastoma - Preliminary Results of 18F-FDOPA MR-PET 417 10-10 22:50
4291 O-03 Analysis of the clinical outcome of high-risk neuroblastoma: Results from the a late phase II study of Japan Neuroblastoma Study Group (JNBSG) JN-H-07 421 10-10 22:28
4290 O-02 Outcome Analysis of Children with Neuroblastoma Between 2003 and 2012 in the Era After Introduction of Modern Risk-Stratified Treatment Protocol: A Report from the Taiwan Pediatric Oncology Group 466 10-10 22:24
4289 O-01 The progress and visions of JNBSG 403 10-10 22:20
4288 K-04 Targeting neuroblastoma and its microenvironment with novel approach 492 10-25 07:51
Prev567891011121314Next Go: / 94